Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

1,070 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 20262025202420232022 2015 All years
Cause Sterility / contaminationNitrosamine impurityChemical / undeclaredParticulate / foreign matterLabeling / mix-upcGMP deviationMicrobial contamination All causes
Class II · Moderate risk

Doxcycline/0.9% NaCl 150 mg/150 mL IV

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1388-2015
Class II · Moderate risk

Vancomycin 25 mg/mL Opthalmic Solution

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1387-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1386-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1385-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1384-2015
Class II · Moderate risk

Methylcobalamin 5000 mcg/mL Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1382-2015
Class II · Moderate risk

Papaverine/Phentolamine/PGE-1 Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1381-2015
Class II · Moderate risk

Cyanocobalamin 500 mcg/mL Injectable

Lack of Assurance of Sterility: Process deficiencies were observed in the sterile ophthalmic and injectable products that could have compromised the sterility of the product.

Terminated Sterility / contamination Liberty Drug & Surgical D-1380-2015
Class II · Moderate risk

Trypan Blue 0.3%

Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vials.

Terminated Sterility / contamination Vital Care Compounder D-1056-2016
Class II · Moderate risk

Brilliant Blue G BBG

Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vials.

Terminated Sterility / contamination Vital Care Compounder D-1055-2016
Class II · Moderate risk

Methylcobalamin 5

Lack of Assurance of Sterility: Aluminum crimps do not fully seal the rubber stopper to the vials.

Terminated Sterility / contamination Vital Care Compounder D-1054-2016
Class II · Moderate risk

Tri-Mix T-106

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1807-2015
Class II · Moderate risk

Tri-Mix T-105

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1806-2015
Class II · Moderate risk

Tri-Mix T-102

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1804-2015
Class II · Moderate risk

Tri-Mix T-101

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1803-2015
Class II · Moderate risk

Tri-Mix SUPER

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1802-2015
Class II · Moderate risk

Tri-Mix ST9E

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1801-2015
Class II · Moderate risk

Tri-Mix ST9C

Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility

Terminated Sterility / contamination The Compounding Pharmacy of America D-1800-2015

Recalls by year